Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ:LMRI
LMRI Stock Chart & Stats
$12.72
--
Market closed
$12.72
--
Day’s Range― - ―
52-Week Range$7.23 - $19.45
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.53M
Market Cap
$893.82M
Enterprise Value$1.80B
Total Cash (Recent Filing)$58.83M
Total Debt (Recent Filing)$960.90M
Price to Earnings (P/E)―
Beta3.13
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding96,109,924
10 Day Avg. Volume1,530,126
30 Day Avg. Volume1,530,126
Financial Highlights & Ratios
PEG Ratio0.82
Price to Book (P/B)2.24
Price to Sales (P/S)1.28
P/FCF Ratio-205.07
Enterprise Value/Market Cap2.01
Enterprise Value/Revenue6.71
Enterprise Value/Gross Profit60.43
Enterprise Value/Ebitda364.65
Forecast
1Y Price Target
$20.67Price Target Upside62.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue & Adjusted EBITDA GrowthSustained top-line growth with simultaneous adjusted EBITDA expansion indicates durable demand for advanced outpatient imaging. This revenue and margin momentum supports operating leverage, funds network expansion, and underpins a credible multi-year path to consistent profitability if trends continue.
Meaningful Deleveraging And Liquidity BuildMaterial debt paydown and higher cash improved credit metrics and lower interest costs, increasing financial flexibility. Structural deleveraging reduces refinancing risk, frees cash for capex or tuck-ins, and strengthens runway to execute expansion and tech investments over the next several years.
Technology & Throughput ImprovementsPersistent productivity gains from FastScan, virtual cockpit and AI materially raise capacity per center, lower unit labor costs, and shorten de‑novo breakeven. Structural tech adoption supports scalable growth, higher acuity mix and margin sustainability as the network expands over time.
Bears Say
Ongoing GAAP Net LossesDespite operating improvements, persistent GAAP losses indicate the company has not fully converted operating performance into bottom-line profitability. Continued net losses can erode equity, limit retained earnings, and may necessitate further financing until sustained net profits are achieved.
Weakened Cash Generation In 2025Negative free cash flow and falling operating cash flow signal weaker earnings-to-cash conversion and higher working capital strain. Structurally, this raises reliance on external capital, constrains reinvestment capacity, and increases sensitivity to funding costs over the medium term.
High Capital Intensity & Limited CapEx VisibilityOngoing large capital requirements for new centers and equipment create durable cash needs. Lack of clear near-term CapEx guidance increases modeling risk and could delay free cash flow normalization, stressing funding plans despite recent deleveraging progress.
Lumexa Imaging Holdings, Inc. News
LMRI FAQ
What was Lumexa Imaging Holdings, Inc.’s price range in the past 12 months?
Lumexa Imaging Holdings, Inc. lowest stock price was $7.23 and its highest was $19.45 in the past 12 months.
What is Lumexa Imaging Holdings, Inc.’s market cap?
Lumexa Imaging Holdings, Inc.’s market cap is $893.82M.
When is Lumexa Imaging Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lumexa Imaging Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Lumexa Imaging Holdings, Inc. overvalued?
According to Wall Street analysts Lumexa Imaging Holdings, Inc.’s price is currently Undervalued.
Does Lumexa Imaging Holdings, Inc. pay dividends?
Lumexa Imaging Holdings, Inc. does not currently pay dividends.
What is Lumexa Imaging Holdings, Inc.’s EPS estimate?
Lumexa Imaging Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lumexa Imaging Holdings, Inc. have?
Lumexa Imaging Holdings, Inc. has 96,109,924 shares outstanding.
What happened to Lumexa Imaging Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lumexa Imaging Holdings, Inc.?
Currently, no hedge funds are holding shares in LMRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lumexa Imaging Holdings, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.67 (62.47% Upside)
$20.67 (62.47% Upside)
Blogger Sentiment
Bullish
LMRI Sentiment 100%
Sector Average 67%
Sector Average 67%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
-18.34%
Trailing 12-Months
Asset Growth
5.86%
Trailing 12-Months
Company Description
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. The company was founded in 2018 and is based in Raleigh, North Carolina.
LMRI Earnings Call
Q4 2026
0:00 / 0:00
LMRI Stock 12 Month Forecast
Average Price Target
$20.67
▲(62.47% Upside)